175 related articles for article (PubMed ID: 19174824)
1. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.
Majeed F; Kop WJ; Poston RS; Kallam S; Mehra MR
Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):147-57. PubMed ID: 19174824
[TBL] [Abstract][Full Text] [Related]
2. Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: a single-center experience.
Fiore M; James C; Mouton C; Calderon J; Barandon L; Ouattara A; Picard F
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3119-25.e1. PubMed ID: 25212058
[TBL] [Abstract][Full Text] [Related]
3. Extensive coagulation monitoring in patients after implantation of the MicroMed Debakey continuous flow axial pump.
Bonaros N; Mueller MR; Salat A; Schima H; Roethy W; Kocher AA; Wolner E; Wieselthaler GM
ASAIO J; 2004; 50(5):424-31. PubMed ID: 15497380
[TBL] [Abstract][Full Text] [Related]
4. Fixed-dose aspirin monotherapy compared with thromboelastography directed antiplatelet therapy in long-term management of left ventricular assist devices.
Fanelli SJ; Elzeneini M; Meece LE; Mahmoud A; Jeng EI; Harris N; Ahmed MM
J Card Surg; 2022 Sep; 37(9):2621-2628. PubMed ID: 35610463
[TBL] [Abstract][Full Text] [Related]
5. Reduced aspirin responsiveness as assessed by impedance aggregometry is not associated with adverse outcome after cardiac surgery in a small low-risk cohort.
Bolliger D; Filipovic M; Matt P; Tanaka KA; Gregor M; Zenklusen U; Seeberger MD; Lurati Buse G
Platelets; 2016; 27(3):254-61. PubMed ID: 26367099
[TBL] [Abstract][Full Text] [Related]
6. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
van den Bergh WM; Lansink-Hartgring AO; van Duijn AL; Engström AE; Lahpor JR; Slooter AJ
J Cardiothorac Surg; 2015 Oct; 10():128. PubMed ID: 26471178
[TBL] [Abstract][Full Text] [Related]
8. Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis.
Montalto A; Comisso M; Cammardella A; Nicolò F; Gherli R; Palermo A; Pulcinelli F; Musumeci F
Transplant Proc; 2019 Nov; 51(9):2986-2990. PubMed ID: 31711580
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device.
Consolo F; Sferrazza G; Motolone G; Contri R; Valerio L; Lembo R; Pozzi L; Della Valle P; De Bonis M; Zangrillo A; Fiore GB; Redaelli A; Slepian MJ; Pappalardo F
Eur J Heart Fail; 2018 Apr; 20(4):792-800. PubMed ID: 29282819
[TBL] [Abstract][Full Text] [Related]
10. Aspirin resistance in patients with ventricular assist devices: A follow-up study.
Flieder T; Blaesen S; Schulte K; Blasberg J; Lauenroth V; Knabbe C; Schramm R; Morshuis M; Gummert J; Birschmann I
Artif Organs; 2024 Jul; 48(7):781-788. PubMed ID: 38553978
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.
Baumann Kreuziger LM; Kim B; Wieselthaler GM
J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489
[TBL] [Abstract][Full Text] [Related]
12. Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease.
Hallén J; Atar D; Serebruany V
Am J Ther; 2014; 21(2):91-8. PubMed ID: 19770797
[TBL] [Abstract][Full Text] [Related]
13. Effect of low dose aspirin on augmented plasminogen activator inhibitor type 1 activity in patients with permanent pacemakers.
Abe H; Takahara K; Nakashima Y; Kuroiwa A
Pacing Clin Electrophysiol; 1994 Feb; 17(2):146-51. PubMed ID: 7513398
[TBL] [Abstract][Full Text] [Related]
14. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
[TBL] [Abstract][Full Text] [Related]
15. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
[TBL] [Abstract][Full Text] [Related]
16. Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo.
Hampton KK; Cerletti C; Loizou LA; Bucchi F; Donati MB; Davies JA; de Gaetano G; Prentice CR
Thromb Haemost; 1990 Aug; 64(1):17-20. PubMed ID: 2073296
[TBL] [Abstract][Full Text] [Related]
17. Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses.
García-Rinaldi R; Carro-Pagán C; Schaff HV; McKellar SH; Thompson JL; Quiñones J; Rodríguez-Acosta JF
J Heart Valve Dis; 2009 Nov; 18(6):617-25; discussion 626. PubMed ID: 20099710
[TBL] [Abstract][Full Text] [Related]
18. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I
Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
20. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
